Stepan (SCL) Competitors $62.76 -1.15 (-1.80%) Closing price 03:59 PM EasternExtended Trading$62.59 -0.17 (-0.27%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends SCL vs. BCPC, NEU, FUL, ASH, SXT, IOSP, KWR, MTX, FTK, and FFShould you be buying Stepan stock or one of its competitors? The main competitors of Stepan include Balchem (BCPC), NewMarket (NEU), H.B. Fuller (FUL), Ashland (ASH), Sensient Technologies (SXT), Innospec (IOSP), Quaker Chemical (KWR), Minerals Technologies (MTX), Flotek Industries (FTK), and FutureFuel (FF). These companies are all part of the "specialty chemicals" industry. Stepan vs. Balchem NewMarket H.B. Fuller Ashland Sensient Technologies Innospec Quaker Chemical Minerals Technologies Flotek Industries FutureFuel Stepan (NYSE:SCL) and Balchem (NASDAQ:BCPC) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations. Does the media prefer SCL or BCPC? In the previous week, Stepan had 8 more articles in the media than Balchem. MarketBeat recorded 24 mentions for Stepan and 16 mentions for Balchem. Balchem's average media sentiment score of 1.18 beat Stepan's score of -0.07 indicating that Balchem is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stepan 1 Very Positive mention(s) 6 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Balchem 9 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend SCL or BCPC? Balchem has a consensus price target of $190.00, indicating a potential upside of 16.05%. Given Balchem's stronger consensus rating and higher probable upside, analysts plainly believe Balchem is more favorable than Stepan.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stepan 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Balchem 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SCL or BCPC a better dividend stock? Stepan pays an annual dividend of $1.54 per share and has a dividend yield of 2.5%. Balchem pays an annual dividend of $0.87 per share and has a dividend yield of 0.5%. Stepan pays out 69.7% of its earnings in the form of a dividend. Balchem pays out 23.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stepan has increased its dividend for 57 consecutive years and Balchem has increased its dividend for 16 consecutive years. Stepan is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has stronger earnings and valuation, SCL or BCPC? Balchem has lower revenue, but higher earnings than Stepan. Stepan is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStepan$2.18B0.65$40.20M$2.2128.40Balchem$922.44M5.77$108.54M$3.7244.01 Does the MarketBeat Community favor SCL or BCPC? Balchem received 139 more outperform votes than Stepan when rated by MarketBeat users. Likewise, 66.84% of users gave Balchem an outperform vote while only 55.19% of users gave Stepan an outperform vote. CompanyUnderperformOutperformStepanOutperform Votes25055.19% Underperform Votes20344.81% BalchemOutperform Votes38966.84% Underperform Votes19333.16% Which has more risk and volatility, SCL or BCPC? Stepan has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, Balchem has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Do institutionals and insiders have more ownership in SCL or BCPC? 82.7% of Stepan shares are owned by institutional investors. Comparatively, 87.9% of Balchem shares are owned by institutional investors. 6.9% of Stepan shares are owned by company insiders. Comparatively, 1.3% of Balchem shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is SCL or BCPC more profitable? Balchem has a net margin of 12.90% compared to Stepan's net margin of 2.31%. Balchem's return on equity of 10.99% beat Stepan's return on equity.Company Net Margins Return on Equity Return on Assets Stepan2.31% 4.21% 2.14% Balchem 12.90%10.99%7.65% SummaryBalchem beats Stepan on 15 of the 21 factors compared between the two stocks. Get Stepan News Delivered to You Automatically Sign up to receive the latest news and ratings for SCL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCL vs. The Competition Export to ExcelMetricStepanSoap, detergents, & cleaning preparations; perfumes, & cosmetics IndustryMaterials SectorNYSE ExchangeMarket Cap$1.41B$109.10B$3.12B$20.06BDividend Yield2.46%1.86%5.15%3.65%P/E Ratio28.4022.63104.0634.89Price / Sales0.653.2125,886,820,843,820,000.0015.65Price / Cash8.9619.7424.3720.85Price / Book1.215.474.934.92Net Income$40.20M$4.03B$152.38M$1.02B7 Day Performance1.73%1.02%-0.86%-1.05%1 Month Performance-4.38%1.01%2.03%-1.39%1 Year Performance-30.83%1.79%32.57%13.93% Stepan Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLStepan3.8358 of 5 stars$62.76-1.8%N/A-29.6%$1.41B$2.18B28.402,389Earnings ReportDividend AnnouncementAnalyst DowngradeNews CoverageBCPCBalchem4.8222 of 5 stars$164.82+1.0%$190.00+15.3%+2.6%$5.36B$922.44M44.311,302Earnings ReportNews CoveragePositive NewsGap UpNEUNewMarket2.2928 of 5 stars$542.04-1.0%N/A-10.2%$5.20B$2.79B11.242,000Analyst DowngradeNews CoverageFULH.B. Fuller4.5238 of 5 stars$60.67+0.3%$75.60+24.6%-24.0%$3.32B$3.57B26.277,500Short Interest ↓ASHAshland4.6226 of 5 stars$64.92-0.1%$95.57+47.2%-28.8%$3.06B$2.11B-98.363,200SXTSensient Technologies3.962 of 5 stars$71.38-7.3%$85.00+19.1%+7.4%$3.02B$1.46B34.153,956Earnings ReportHigh Trading VolumeIOSPInnospec3.5538 of 5 stars$108.19-3.2%N/A-16.4%$2.70B$1.95B18.882,400Earnings ReportAnalyst RevisionNews CoverageKWRQuaker Chemical4.4846 of 5 stars$140.12-0.6%$177.33+26.6%-28.0%$2.49B$1.95B20.544,400Dividend AnnouncementNews CoverageMTXMinerals Technologies4.4963 of 5 stars$71.50-3.2%$101.00+41.3%-0.4%$2.28B$2.12B13.804,070FTKFlotek Industries2.1611 of 5 stars$9.04-1.3%$7.50-17.0%+166.1%$269.24M$188.06M34.75130Positive NewsFFFutureFuel4.1472 of 5 stars$4.90-0.5%$0.80-83.7%-17.4%$214.21M$368.25M5.97470News Coverage Related Companies and Tools Related Companies Balchem Alternatives NewMarket Alternatives H.B. Fuller Alternatives Ashland Alternatives Sensient Technologies Alternatives Innospec Alternatives Quaker Chemical Alternatives Minerals Technologies Alternatives Flotek Industries Alternatives FutureFuel Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:SCL) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stepan Please log in to your account or sign up in order to add this asset to your watchlist. Share Stepan With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
